个人中心 - 老虎社区

Ytyt

IP属地：未知

帖子 · 69帖子 · 69
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- YtytYtyt
  ·2021-12-30
  Pls like
  非常抱歉，此主贴已删除
  1,977 1
  4
  分享
  举报
- YtytYtyt
  ·2021-12-28
  Pls like
  Novavax shares dropped another 4% in premarket trading
  Novavax shares dropped another 4% in premarket trading.The stock plunged nearly 11% yesterday. Why
  Novavax shares dropped another 4% in premarket trading
  1,262 3
  7
  分享
  举报
- YtytYtyt
  ·2021-12-26
  Pls like
  非常抱歉，此主贴已删除
  1,395 2
  7
  分享
  举报
- YtytYtyt
  ·2021-12-25
  Pls like
  非常抱歉，此主贴已删除
  2,174 3
  5
  分享
  举报
- YtytYtyt
  ·2021-12-24
  Pls like
  非常抱歉，此主贴已删除
  1,092 2
  7
  分享
  举报
- YtytYtyt
  ·2021-12-23
  Pls like
  非常抱歉，此主贴已删除
  1,344 1
  3
  分享
  举报
- YtytYtyt
  ·2021-12-22
  Pls like
  非常抱歉，此主贴已删除
  1,414 3
  6
  分享
  举报
- YtytYtyt
  ·2021-12-21
  Pls like
  MRNA, NVAX, OCGN, PFE, BNTX: What Is Going on With Vaccine Stocks Today?
  As another week kicks off on Wall Street, it’s clear that the ominous coverage of the spreading omic
  MRNA, NVAX, OCGN, PFE, BNTX: What Is Going on With Vaccine Stocks Today?
  1,363 1
  2
  分享
  举报
- YtytYtyt
  ·2021-12-20
  Pls like
  Singapore Stock Market May Give Up Support At 3,100 Points
  The Singapore stock market has alternated between positive and negative finishes through the last fo
  Singapore Stock Market May Give Up Support At 3,100 Points
  1,979 2
  4
  分享
  举报
- YtytYtyt
  ·2021-12-18
  Pls like
  非常抱歉，此主贴已删除
  1,103 评论
  5
  分享
  举报
暂无粉丝

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"4094269572113460","uuid":"4094269572113460","gmtCreate":1631257775982,"gmtModify":1631257775982,"name":"Ytyt","pinyin":"ytyt","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":8,"headSize":279,"tweetSize":69,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.01.02","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":692999360,"gmtCreate":1640821878867,"gmtModify":1640821879094,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094269572113460","authorIdStr":"4094269572113460"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/692999360","repostId":"2195466435","repostType":4,"isVote":1,"tweetType":1,"viewCount":1977,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696664524,"gmtCreate":1640685161869,"gmtModify":1640685637729,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094269572113460","authorIdStr":"4094269572113460"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/696664524","repostId":"1138246031","repostType":4,"repost":{"id":"1138246031","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640683578,"share":"https://www.laohunote.com/m/news/1138246031?lang=&edition=full","pubTime":"2021-12-28 17:26","market":"us","language":"en","title":"Novavax shares dropped another 4% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1138246031","media":"Tiger Newspress","summary":"Novavax shares dropped another 4% in premarket trading.The stock plunged nearly 11% yesterday.\n\nWhy ","content":"<p>Novavax shares dropped another 4% in premarket trading.The stock plunged&nbsp;nearly 11% yesterday.</p>\n<p><img src=\"https://static.tigerbbs.com/04a11fff9a31214bbcf7595183a5d305\" tg-width=\"843\" tg-height=\"618\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Why Novavax Stock Is Sinking</b></p>\n<p>The company didn't announce any new developments. So what's behind the big decline?</p>\n<p>Other&nbsp;vaccine stocks&nbsp;aren't falling nearly as much. Some were even up a little. That rules out the likelihood that declining concerns about the omicron variant played a major factor behind Novavax's drop.</p>\n<p>Instead, investors are probably growing more anxious about Novavax's planned filing for U.S. Emergency Use Authorization (EUA) of it COVID-19 vaccine NVX-CoV2373. Some investors could also be worried about the quality of Novavax's submission to the Food and Drug Administration (FDA) even if it doesn't experience another delay with the filing.</p>\n<p>CEO Stanley Erck's interview with Yahoo! Finance Live last Thursday likely didn't help reassure investors. When asked about when the FDA filing would be done, Erck replied, \"It's probably going to be next week, but I'm sticking with the claim that we'll be doing this by the end of this year.\"</p>\n<p><b>So what</b></p>\n<p>Yet another delay in a U.S. filing for NVX-CoV2373 wouldn't be catastrophic for Novavax as long as the company completes the submission soon in the new year. However, management's credibility would definitely take another big blow.</p>\n<p>But it's premature at this point to speculate that Novavax won't complete the U.S. EUA filing this week. It's also useless to fret about the quality of the company's FDA package. Novavax recently won European Union authorization for NVX-CoV2373. That shows that the vaccine maker can successfully meet regulators' manufacturing-quality hurdles.</p>\n<p><b>Now what</b></p>\n<p>Investors don't like waiting, but that's exactly what they'll have to do for now with Novavax. The company could complete its EUA filing any day now. It could also pick up new authorizations in other countries where it awaits regulatory decisions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax shares dropped another 4% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax shares dropped another 4% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-28 17:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Novavax shares dropped another 4% in premarket trading.The stock plunged&nbsp;nearly 11% yesterday.</p>\n<p><img src=\"https://static.tigerbbs.com/04a11fff9a31214bbcf7595183a5d305\" tg-width=\"843\" tg-height=\"618\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Why Novavax Stock Is Sinking</b></p>\n<p>The company didn't announce any new developments. So what's behind the big decline?</p>\n<p>Other&nbsp;vaccine stocks&nbsp;aren't falling nearly as much. Some were even up a little. That rules out the likelihood that declining concerns about the omicron variant played a major factor behind Novavax's drop.</p>\n<p>Instead, investors are probably growing more anxious about Novavax's planned filing for U.S. Emergency Use Authorization (EUA) of it COVID-19 vaccine NVX-CoV2373. Some investors could also be worried about the quality of Novavax's submission to the Food and Drug Administration (FDA) even if it doesn't experience another delay with the filing.</p>\n<p>CEO Stanley Erck's interview with Yahoo! Finance Live last Thursday likely didn't help reassure investors. When asked about when the FDA filing would be done, Erck replied, \"It's probably going to be next week, but I'm sticking with the claim that we'll be doing this by the end of this year.\"</p>\n<p><b>So what</b></p>\n<p>Yet another delay in a U.S. filing for NVX-CoV2373 wouldn't be catastrophic for Novavax as long as the company completes the submission soon in the new year. However, management's credibility would definitely take another big blow.</p>\n<p>But it's premature at this point to speculate that Novavax won't complete the U.S. EUA filing this week. It's also useless to fret about the quality of the company's FDA package. Novavax recently won European Union authorization for NVX-CoV2373. That shows that the vaccine maker can successfully meet regulators' manufacturing-quality hurdles.</p>\n<p><b>Now what</b></p>\n<p>Investors don't like waiting, but that's exactly what they'll have to do for now with Novavax. The company could complete its EUA filing any day now. It could also pick up new authorizations in other countries where it awaits regulatory decisions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1138246031","content_text":"Novavax shares dropped another 4% in premarket trading.The stock plunged nearly 11% yesterday.\n\nWhy Novavax Stock Is Sinking\nThe company didn't announce any new developments. So what's behind the big decline?\nOther vaccine stocks aren't falling nearly as much. Some were even up a little. That rules out the likelihood that declining concerns about the omicron variant played a major factor behind Novavax's drop.\nInstead, investors are probably growing more anxious about Novavax's planned filing for U.S. Emergency Use Authorization (EUA) of it COVID-19 vaccine NVX-CoV2373. Some investors could also be worried about the quality of Novavax's submission to the Food and Drug Administration (FDA) even if it doesn't experience another delay with the filing.\nCEO Stanley Erck's interview with Yahoo! Finance Live last Thursday likely didn't help reassure investors. When asked about when the FDA filing would be done, Erck replied, \"It's probably going to be next week, but I'm sticking with the claim that we'll be doing this by the end of this year.\"\nSo what\nYet another delay in a U.S. filing for NVX-CoV2373 wouldn't be catastrophic for Novavax as long as the company completes the submission soon in the new year. However, management's credibility would definitely take another big blow.\nBut it's premature at this point to speculate that Novavax won't complete the U.S. EUA filing this week. It's also useless to fret about the quality of the company's FDA package. Novavax recently won European Union authorization for NVX-CoV2373. That shows that the vaccine maker can successfully meet regulators' manufacturing-quality hurdles.\nNow what\nInvestors don't like waiting, but that's exactly what they'll have to do for now with Novavax. The company could complete its EUA filing any day now. It could also pick up new authorizations in other countries where it awaits regulatory decisions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1262,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698432662,"gmtCreate":1640488189966,"gmtModify":1640488190120,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094269572113460","authorIdStr":"4094269572113460"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/698432662","repostId":"2193917872","repostType":4,"isVote":1,"tweetType":1,"viewCount":1395,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698217515,"gmtCreate":1640405186348,"gmtModify":1640405186490,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094269572113460","authorIdStr":"4094269572113460"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/698217515","repostId":"2193720178","repostType":4,"isVote":1,"tweetType":1,"viewCount":2174,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698333952,"gmtCreate":1640302602178,"gmtModify":1640302602541,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094269572113460","authorIdStr":"4094269572113460"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/698333952","repostId":"2193078140","repostType":4,"isVote":1,"tweetType":1,"viewCount":1092,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691270758,"gmtCreate":1640216306020,"gmtModify":1640216306127,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094269572113460","authorIdStr":"4094269572113460"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/691270758","repostId":"2193113147","repostType":4,"isVote":1,"tweetType":1,"viewCount":1344,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691954726,"gmtCreate":1640130161579,"gmtModify":1640130161850,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094269572113460","authorIdStr":"4094269572113460"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/691954726","repostId":"2193663561","repostType":4,"isVote":1,"tweetType":1,"viewCount":1414,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693724197,"gmtCreate":1640085463691,"gmtModify":1640085463794,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094269572113460","authorIdStr":"4094269572113460"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/693724197","repostId":"1173202355","repostType":2,"repost":{"id":"1173202355","kind":"news","pubTimestamp":1640053734,"share":"https://www.laohunote.com/m/news/1173202355?lang=&edition=full","pubTime":"2021-12-21 10:28","market":"us","language":"en","title":"MRNA, NVAX, OCGN, PFE, BNTX: What Is Going on With Vaccine Stocks Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=1173202355","media":"InvestorPlace","summary":"As another week kicks off on Wall Street, it’s clear that the ominous coverage of the spreading omic","content":"<p>As another week kicks off on Wall Street, it’s clear that the ominous coverage of the spreading omicron variant is still casting shadows over markets. This week has started off with mixed news surrounding the companies who are working around the clock to get ahead in the vaccine race. This has been making it difficult for the overall sector to gain the type of momentum it needs for all vaccine stocks to start moving upward. While one company has an encouraging update regarding its vaccine’s effectiveness against the variant, most of its peers haven’t been so lucky.</p>\n<p>What’s Going on With Vaccine Stocks?</p>\n<p>For the companies embedded in the race to beat the variant, this week isn’t off to a good start. Indeed, vaccine stocks are facing noticeable turbulence.<b>Moderna</b>(NASDAQ:<b><u>MRNA</u></b>) began the day with the announcement that a third dose of its Covid-19 vaccine has been proven to&nbsp;increase antibodies against the new variant. Even with such reassuring news, MRNA stock is down 6.25% today. That said, it did cause shares to surge this morning, putting MRNA stock up almost 10% for the week.</p>\n<p>Meanwhile, most of its peers aren’t fairing much better.<b>Novavax</b>(NASDAQ:<b><u>NVAX</u></b>) just received&nbsp;authorization&nbsp;from the European Union to begin distributing its vaccine throughout Europe during the first half of 2022. While this news sent the stock up in premarket trading today, it hasn’t done much since then. NVAX stock is down more than 7% today. Additionally,&nbsp;<b>Ocugen</b>(NASDAQ:<b><u>OCGN</u></b>) is also falling after an initial&nbsp;early day rise&nbsp;driven by superficial catalysts.</p>\n<p>The only vaccine stock in the green this morning is&nbsp;<b>Pfizer</b>(NYSE:<b><u>PFE</u></b>), which is up more than 2% today despite the&nbsp;recent setback&nbsp;the company experienced regarding its vaccine for children five years old and younger. Meanwhile, Pfizer’s vaccine production partner, Germany-based&nbsp;<b>BioNTech</b>(NASDAQ:<b><u>BNTX</u></b>) is down 4.19% so far, despite the&nbsp;recent news&nbsp;that the two companies will be providing more than 200 million additional vaccine doses to the EU in 2022.</p>\n<p>Why It Matters</p>\n<p>While the week is off to a rough start, every company on this list is still up for the week. The only exception is OCGN, which seems more like a meme stock that is losing momentum.</p>\n<p>However, every other name on this list is fair game for a bullish play on vaccine stocks. The new data from Moderna is highly encouraging, in no small part because it likely means that Pfizer won’t be far behind in tailoring its own vaccine to effectively fight the omicron variant. Novavax’s news is also cause for optimism. While it hasn’t helped the stock rise this morning, it does suggest that global vaccine efforts are moving forward. The same could be said for the recent EU news regarding Pfizer and BioNTech. Novavax has been working hard to gain its place among the vaccine producers that helped us beat the pandemic’s earlier waves. And this looks like an opportunity for it to do exactly that.</p>\n<p>What It Means</p>\n<p>Despite today’s downturn, we will likely see another vaccine stock boom in 2022. Indeed, this will come as companies make real strides against the omicron variant.</p>\n<p>Regardless of exactly how that shakes out, world leaders are going to be working hard to speed up global vaccination efforts to ensure that new variants don’t emerge and complicate matters further. Every stock on this list, with the exception of OCGN, is worth watching as the new year takes shape.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MRNA, NVAX, OCGN, PFE, BNTX: What Is Going on With Vaccine Stocks Today?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMRNA, NVAX, OCGN, PFE, BNTX: What Is Going on With Vaccine Stocks Today?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-21 10:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/12/mrna-nvax-ocgn-pfe-bntx-what-is-going-on-with-vaccine-stocks-today/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As another week kicks off on Wall Street, it’s clear that the ominous coverage of the spreading omicron variant is still casting shadows over markets. This week has started off with mixed news ...</p>\n\n<a href=\"https://investorplace.com/2021/12/mrna-nvax-ocgn-pfe-bntx-what-is-going-on-with-vaccine-stocks-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen","BNTX":"BioNTech SE","NVAX":"诺瓦瓦克斯医药","PFE":"辉瑞","MRNA":"Moderna, Inc."},"source_url":"https://investorplace.com/2021/12/mrna-nvax-ocgn-pfe-bntx-what-is-going-on-with-vaccine-stocks-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1173202355","content_text":"As another week kicks off on Wall Street, it’s clear that the ominous coverage of the spreading omicron variant is still casting shadows over markets. This week has started off with mixed news surrounding the companies who are working around the clock to get ahead in the vaccine race. This has been making it difficult for the overall sector to gain the type of momentum it needs for all vaccine stocks to start moving upward. While one company has an encouraging update regarding its vaccine’s effectiveness against the variant, most of its peers haven’t been so lucky.\nWhat’s Going on With Vaccine Stocks?\nFor the companies embedded in the race to beat the variant, this week isn’t off to a good start. Indeed, vaccine stocks are facing noticeable turbulence.Moderna(NASDAQ:MRNA) began the day with the announcement that a third dose of its Covid-19 vaccine has been proven to increase antibodies against the new variant. Even with such reassuring news, MRNA stock is down 6.25% today. That said, it did cause shares to surge this morning, putting MRNA stock up almost 10% for the week.\nMeanwhile, most of its peers aren’t fairing much better.Novavax(NASDAQ:NVAX) just received authorization from the European Union to begin distributing its vaccine throughout Europe during the first half of 2022. While this news sent the stock up in premarket trading today, it hasn’t done much since then. NVAX stock is down more than 7% today. Additionally, Ocugen(NASDAQ:OCGN) is also falling after an initial early day rise driven by superficial catalysts.\nThe only vaccine stock in the green this morning is Pfizer(NYSE:PFE), which is up more than 2% today despite the recent setback the company experienced regarding its vaccine for children five years old and younger. Meanwhile, Pfizer’s vaccine production partner, Germany-based BioNTech(NASDAQ:BNTX) is down 4.19% so far, despite the recent news that the two companies will be providing more than 200 million additional vaccine doses to the EU in 2022.\nWhy It Matters\nWhile the week is off to a rough start, every company on this list is still up for the week. The only exception is OCGN, which seems more like a meme stock that is losing momentum.\nHowever, every other name on this list is fair game for a bullish play on vaccine stocks. The new data from Moderna is highly encouraging, in no small part because it likely means that Pfizer won’t be far behind in tailoring its own vaccine to effectively fight the omicron variant. Novavax’s news is also cause for optimism. While it hasn’t helped the stock rise this morning, it does suggest that global vaccine efforts are moving forward. The same could be said for the recent EU news regarding Pfizer and BioNTech. Novavax has been working hard to gain its place among the vaccine producers that helped us beat the pandemic’s earlier waves. And this looks like an opportunity for it to do exactly that.\nWhat It Means\nDespite today’s downturn, we will likely see another vaccine stock boom in 2022. Indeed, this will come as companies make real strides against the omicron variant.\nRegardless of exactly how that shakes out, world leaders are going to be working hard to speed up global vaccination efforts to ensure that new variants don’t emerge and complicate matters further. Every stock on this list, with the exception of OCGN, is worth watching as the new year takes shape.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1363,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693917743,"gmtCreate":1639960563499,"gmtModify":1639960563638,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094269572113460","authorIdStr":"4094269572113460"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/693917743","repostId":"1154958924","repostType":4,"repost":{"id":"1154958924","kind":"news","pubTimestamp":1639958978,"share":"https://www.laohunote.com/m/news/1154958924?lang=&edition=full","pubTime":"2021-12-20 08:09","market":"sg","language":"en","title":"Singapore Stock Market May Give Up Support At 3,100 Points","url":"https://stock-news.laohu8.com/highlight/detail?id=1154958924","media":"RTTNews","summary":"The Singapore stock market has alternated between positive and negative finishes through the last fo","content":"<p>The Singapore stock market has alternated between positive and negative finishes through the last four trading days since the end of the two-day slide in which it had fallen more than 20 points or 0.7 percent. The Straits Times Index now sits just above the 3,110-point plateau and it may take further damage again on Monday.</p>\n<p>The global forecast for the Asian&nbsp;markets&nbsp;is soft on omicron coronavirus concerns and sinking oil prices. The European markets were mixed and the U.S. bourses were down and the Asian markets figure to split the difference.</p>\n<p>The STI finished modestly lower on Friday following losses from the industrials and properties, while the financials came in mixed.</p>\n<p>For the day, the index lost 17.17 points or 0.55 percent to finish at the daily low of 3,111.63 after peaking at 3,134.99. Volume was 1.2 billion shares worth 1.5 billion Singapore dollars. There were 280 decliners and 188 gainers.</p>\n<p>Among the actives, CapitaLand Integrated Commercial Trust and Mapletree Commercial Trust both slumped 0.50 percent, while City Developments tanked 1.45 percent, Comfort DelGro lost 0.72 percent, Dairy Farm International slid 0.36 percent, DBS Group collected 0.34 percent, Genting Singapore fell 0.65 percent, Hongkong Land plummeted 2.07 percent, Keppel Corp and Venture Corporation both sank 0.97 percent, Mapletree Logistics Trust weakened 0.53 percent, Oversea-Chinese Banking Corporation eased 0.09 percent, SATS skidded 1.03 percent, SembCorp Industries plunged 1.49 percent, Singapore Airlines dropped 0.81 percent, Singapore Exchange tumbled 1.39 percent, Singapore Press Holdings added 0.43 percent, Singapore Technologies Engineering retreated 1.06 percent, SingTel stumbled 0.63 percent, Thai Beverage shed 0.75 percent, United Overseas Bank dipped 0.30 percent, Wilmar International declined 1.21 percent and Yangzijiang Shipbuilding and Ascendas REIT were unchanged.</p>\n<p>The lead from Wall Street is negative as the major averages opened lower on a volatile Friday. The NASDAQ peeked briefly into the green but the markets all still finished in the red.</p>\n<p>The Dow plunged 532.16 points or 1.48 percent to finish at 35,365.44, while the NASDAQ dipped 10.72 points or 0.07 percent to close at 15,169.68 and the S&amp;P 500 sank 48.03 points or 1.03 percent to end at 4,620.64. For the week, the NASDAQ plunged 2.9 percent, the Dow lost 1.7 percent and the S&amp;P was down 1.9 percent.</p>\n<p>The volatility on Wall Street came on a quadruple witching day, with stock options, index options, stock futures and index futures all expiring.</p>\n<p>Concerns about the impact of the Omicron variant of the&nbsp;coronavirus&nbsp;also weighed on the markets along with worries about ongoing supply chain issues.</p>\n<p>Crude oil prices tumbled Friday on concerns for energy demand due to a rapid surge in Omicron variant of the coronavirus and reimposition of restrictions. West Texas Intermediate Crude oil futures for January sank $1.52 or 2.1 percent at $70.86 a barrel. WTI crude futures shed 1.1 percent in the week.</p>","source":"lsy1626938412129","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Singapore Stock Market May Give Up Support At 3,100 Points</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSingapore Stock Market May Give Up Support At 3,100 Points\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-20 08:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.rttnews.com/3250329/singapore-stock-market-may-give-up-support-at-3100-points.aspx><strong>RTTNews</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Singapore stock market has alternated between positive and negative finishes through the last four trading days since the end of the two-day slide in which it had fallen more than 20 points or 0.7...</p>\n\n<a href=\"https://www.rttnews.com/3250329/singapore-stock-market-may-give-up-support-at-3100-points.aspx\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.rttnews.com/3250329/singapore-stock-market-may-give-up-support-at-3100-points.aspx","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154958924","content_text":"The Singapore stock market has alternated between positive and negative finishes through the last four trading days since the end of the two-day slide in which it had fallen more than 20 points or 0.7 percent. The Straits Times Index now sits just above the 3,110-point plateau and it may take further damage again on Monday.\nThe global forecast for the Asian markets is soft on omicron coronavirus concerns and sinking oil prices. The European markets were mixed and the U.S. bourses were down and the Asian markets figure to split the difference.\nThe STI finished modestly lower on Friday following losses from the industrials and properties, while the financials came in mixed.\nFor the day, the index lost 17.17 points or 0.55 percent to finish at the daily low of 3,111.63 after peaking at 3,134.99. Volume was 1.2 billion shares worth 1.5 billion Singapore dollars. There were 280 decliners and 188 gainers.\nAmong the actives, CapitaLand Integrated Commercial Trust and Mapletree Commercial Trust both slumped 0.50 percent, while City Developments tanked 1.45 percent, Comfort DelGro lost 0.72 percent, Dairy Farm International slid 0.36 percent, DBS Group collected 0.34 percent, Genting Singapore fell 0.65 percent, Hongkong Land plummeted 2.07 percent, Keppel Corp and Venture Corporation both sank 0.97 percent, Mapletree Logistics Trust weakened 0.53 percent, Oversea-Chinese Banking Corporation eased 0.09 percent, SATS skidded 1.03 percent, SembCorp Industries plunged 1.49 percent, Singapore Airlines dropped 0.81 percent, Singapore Exchange tumbled 1.39 percent, Singapore Press Holdings added 0.43 percent, Singapore Technologies Engineering retreated 1.06 percent, SingTel stumbled 0.63 percent, Thai Beverage shed 0.75 percent, United Overseas Bank dipped 0.30 percent, Wilmar International declined 1.21 percent and Yangzijiang Shipbuilding and Ascendas REIT were unchanged.\nThe lead from Wall Street is negative as the major averages opened lower on a volatile Friday. The NASDAQ peeked briefly into the green but the markets all still finished in the red.\nThe Dow plunged 532.16 points or 1.48 percent to finish at 35,365.44, while the NASDAQ dipped 10.72 points or 0.07 percent to close at 15,169.68 and the S&P 500 sank 48.03 points or 1.03 percent to end at 4,620.64. For the week, the NASDAQ plunged 2.9 percent, the Dow lost 1.7 percent and the S&P was down 1.9 percent.\nThe volatility on Wall Street came on a quadruple witching day, with stock options, index options, stock futures and index futures all expiring.\nConcerns about the impact of the Omicron variant of the coronavirus also weighed on the markets along with worries about ongoing supply chain issues.\nCrude oil prices tumbled Friday on concerns for energy demand due to a rapid surge in Omicron variant of the coronavirus and reimposition of restrictions. West Texas Intermediate Crude oil futures for January sank $1.52 or 2.1 percent at $70.86 a barrel. WTI crude futures shed 1.1 percent in the week.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1979,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699154850,"gmtCreate":1639758518349,"gmtModify":1639758518490,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094269572113460","authorIdStr":"4094269572113460"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/699154850","repostId":"2192497854","repostType":4,"isVote":1,"tweetType":1,"viewCount":1103,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"followers","isTTM":false}